Search the Newsreel

REG - Sylvania Platinum - Fourth Quarter Operations Report to 30 June 2026

Vivani Medical (NASDAQ: VANI) grants COO options and performance RSUs

Vivani Medical (NASDAQ: VANI) has awarded its Chief Operations Officer, Le Truc, equity compensation including 160,000 stock options at an exercise price of $1.31 per share and 80,000 performance-based Restricted Stock Units (RSUs). The RSUs are tied to achieving a $3.15 share price hurdle …

Vivani Medical (VANI) awards 70,000 options and 35,000 RSUs to CBO

Vivani Medical, Inc. (VANI) has awarded its Chief Business Officer, Donald Dwyer, 70,000 common stock options and 35,000 performance-based Restricted Stock Units (RSUs). The options have a 10-year term and an exercise price of $1.31, vesting over 36 months, while the RSUs vest in …

Vivani Medical Inc. Revenue Breakdown – SWB:U5P

This page provides financial data and a revenue breakdown for Vivani Medical Inc. (SWB:U5P) listed on the Stuttgart Stock Exchange. It includes an overview of financials, statements, statistics, dividends, earnings, and segments, detailing performance by source and country. The page is part of TradingView, …

Univest Financial (NasdaqGS:UVSP) Stock Price

Univest Financial (UVSP) stock is currently trading at US$44.24, which is 2.4% undervalued compared to its fair value estimate of US$45.33. Analysts have recently updated their fair value estimate for UVSP to $45.33, citing strong revenue growth, profit margins, and a positive future P/E …

VANI|Vivani Medical Inc|Price:1.295|Chg%:-0.015

This article provides a comprehensive stock analysis of Vivani Medical Inc (VANI). It highlights that VANI's fundamentals are relatively healthy with significant growth potential, its valuation is considered fair within its industry, and institutional ownership is very high. The company, a clinical-stage biopharmaceutical firm, …

Vivani Medical, Inc. (VANI) awards stock options in lieu of director fees

Vivani Medical, Inc. (VANI) awarded director Daniel Bradbury 7,965 non-qualified stock options at an exercise price of $1.30 per share. These options, which vest quarterly through December 31, 2026, were granted in lieu of $8,000 in cash retainer fees for his increased committee service. …

UNIVEST FINANCIAL Corp Q2 2026: Revenue $84.4M, EPS $0.82— 10-Q Summary

UNIVEST FINANCIAL Corp (UVSP) reported its Q2 2026 results, showing revenue of $84.4 million and diluted EPS of $0.82. The company experienced a 4.2% increase in revenue and an 18.8% increase in diluted EPS year-over-year, driven by growth in net interest income and fee-based …

Univest Financial Corp (UVSP) Balance Sheet

This article provides the quarterly and annual balance sheets for Univest Financial Corp (UVSP), outlining its assets, liabilities, and shareholders' equity over several financial years. It includes detailed financial figures and year-over-year percentage changes for various balance sheet components, allowing investors to evaluate the …

Univest Financial makes investor presentation outlining $8.2B franchise, YTD Q2 core PTPP-NCO $67.4M

Univest Financial has released an investor presentation detailing its key financial highlights and strategic priorities. The presentation outlines an $8.2 billion bank franchise with YTD Q2 core PTPP-NCO of $67.4 million, along with details on its diversified fee-income mix and strong liquidity. The company's …

Univest Financial (UVSP) highlights YTD 2026 growth, capital and liquidity

Univest Financial Corporation (UVSP) has released an investor presentation detailing its Year-to-Date 2026 operating performance, balance sheet trends, liquidity, and strategy. The $8.2 billion bank reported earnings of $50.0 million ($1.79 per share) and highlighted strong capital ratios and liquidity with $3.7 billion in …

UNIVEST FINANCIAL Corp Buys 21,911 Shares of Amazon.com, Inc. $AMZN

UNIVEST FINANCIAL Corp increased its stake in Amazon.com, Inc. by 9.1% during the first quarter of 2026, purchasing an additional 21,911 shares and bringing its total holdings to 263,495 shares valued at approximately $54.9 million. This makes Amazon the 8th largest holding in UNIVEST …

Univest Financial Corp (UVSP) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Univest Financial Corp (UVSP), outlining its major institutional holders and the types of shareholders. It provides specific percentages for top holders like BlackRock and Dimensional Fund Advisors, along with historical institutional shareholding data and recent changes in …

Vivani Medical Inc (VANI) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Vivani Medical Inc (VANI), listing its major individual shareholders and their respective proportions, as well as institutional holdings. It also provides a breakdown of shareholder types and recent changes in shareholdings by key entities and individuals. The …

Univest Financial Corp (UVSP) Cash Flow Statement

This TradingKey page provides a detailed quarterly and annual cash flow statement for Univest Financial Corp (UVSP), allowing users to assess its financial health. It includes operating, investing, and financing cash flow data, alongside explanations of each metric and how much UVSP generated or …

Vivani Medical Enters into Agreement with Novo Nordisk to Evaluate NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management

Vivani Medical has announced an agreement with Novo Nordisk to evaluate NPM-139, Vivani's semaglutide drug implant designed for chronic weight management. The implant, utilizing Vivani's NanoPortal platform, offers a convenient once or twice-yearly treatment alternative. This collaboration highlights Novo Nordisk's interest in Vivani's technology …

Univest Financial Corp (UVSP) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article for Univest Financial Corp (UVSP) on TradingKey.com aims to provide a revenue breakdown by business segments and regional contributions. However, it explicitly states that the relevant data for both categories have not yet been disclosed by the company. Therefore, the content highlights …

Vivani Medical Inc (VANI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for Vivani Medical Inc (VANI), primarily focusing on its regional revenue contribution for FY2019 and FY2018. The company's revenue data by business segments and profit contribution were not disclosed. Key regions mentioned with revenue figures include the United …

Univest Financial Corp (UVSP) Q2 2026 Earnings Call Highlights: Strong Loan and Deposit Growth ...

Univest Financial Corp (UVSP) reported a strong Q2 2026 with an 18.8% increase in earnings per share, driven by robust loan and deposit growth and an expanded net interest margin. The company engaged in significant stock buybacks. However, earnings were negatively impacted by a …

Sylvania Platinum Ltd. Revenue Breakdown – LSE:SLP

Univest Financial Corp (UVSP) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Univest Financial Corp (UVSP), highlighting its current valuation score of 7.09 within the Banking Services industry. It notes UVSP's P/E ratio is 13.15, which is slightly below its recent high but significantly above its recent low. The …

Univest Corporation of Pennsylvania Q2 Earnings Call Highlights

Key Points Interested in Univest Corporation of Pennsylvania? Here are five stocks we like better. Univest posted solid Q2 2026 operating results with net income of $23 million, or $0.82 per share, and EPS up 18.8% year over year. Management said the quarter was …

Enterprise value to revenue forward of Vivani Medical, Inc. – NASDAQ:VANI

This page displays the enterprise value to revenue forward for Vivani Medical, Inc. (NASDAQ: VANI). It provides financial data related to the company, including its performance on the Nasdaq Stock Market. The content is primarily a data point from TradingView's financial section for VANI.

Is Univest Financial Corp (UVSP) Overvalued After Q2 Earnings Miss?

Univest Financial Corp (UVSP) reported a Q2 2026 net income of $23.0 million and diluted EPS of $0.82, an 18.8% increase year-over-year, but missed analyst estimates of $0.86 per share. The company experienced significant loan portfolio growth and increased net interest income, though noninterest …

Earnings call transcript: Univest Financial misses Q2 2026 estimates as shares fall

Univest Financial reported second-quarter 2026 earnings of $0.82 per share on revenue of $84.3 million, missing Wall Street estimates. The miss was primarily attributed to a $5.2 million pre-tax valuation adjustment on an OREO property. Despite the earnings miss and a subsequent 2.95% drop …

Univest Financial reports Q2 net income $23.0M; diluted EPS $0.82, 18.8% YoY gain

Univest Financial (UVSP) reported strong Q2 2026 financial results, with net income rising to $23.0 million and diluted EPS reaching $0.82, an 18.8% increase year-over-year. The company also saw an 11.3% increase in net interest income and significant loan growth, driven by commercial and …

Univest (UVSP) Q2 Earnings and Revenues Lag Estimates

Univest (UVSP) came out with quarterly earnings of $0.82 per share, missing the Zacks Consensus Estimate of $0.86 per share. This compares to earnings of $0.69 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings …

Univest Reports $28.6M Commercial Loan Placed on Nonaccrual Status

Univest Financial reported strong second-quarter 2026 results with diluted EPS increasing 18.8% year-over-year to $0.82 and net interest income rising 11.3%. However, the company also noted an increase in nonperforming assets to $63.0 million, including a $28.6 million commercial loan placed on nonaccrual status …

UVSP Stock Price and Chart — NASDAQ:UVSP

This article provides a detailed overview of Univest Financial Corporation (UVSP) stock, including its current price, historical performance, key financial metrics, and analyst ratings. It highlights the company's recent earnings report, showing a net income increase and stable credit quality, and lists various ETFs …

UNIVEST FINANCIAL Corp Trims Stock Position in Alphabet Inc. $GOOGL

UNIVEST FINANCIAL Corp reduced its stake in Alphabet Inc. (NASDAQ:GOOGL) by 10.6% in the first quarter, selling 28,136 shares. Despite the reduction, Alphabet remains the fourth-largest holding in their portfolio, valued at approximately $68.5 million. Alphabet reported strong quarterly earnings, surpassing analyst expectations for …

KIRAC-GALVANIZ, TCKRC Bilanço

UVSP5023432 Bond Profile — Key Metrics

This article provides a bond profile for UVSP5023432, issued by Univest Financial Corporation. It details key metrics such as the coupon rate of 9.13715%, issue and maturity dates, outstanding amount, and face value. The profile also includes an overview of Univest Financial Corp.'s business …

Enterprise value to EBITDA forward of Vivani Medical Inc. – FWB:U5P

This page from TradingView displays the Enterprise Value to EBITDA forward for Vivani Medical Inc. (FWB:U5P). It indicates that the market was closed at the time of viewing, with no trades reported. The content also briefly touches on financial data providers and legal disclaimers.

Vivani Medical (NASDAQ: VANI) insider buys 793,650 shares at $1.26

Vivani Medical (NASDAQ: VANI) director and 10% owner Gregg Williams reported buying 793,650 shares of common stock in a private sale at $1.26 per share, totaling $999,999.00. This transaction, disclosed in an August 11, 2025 Share Purchase Agreement, increases his beneficial ownership to 41,711,936 …

Vivani Medical (NASDAQ: VANI) Targets August Human Trial For Semaglutide Implant Following Novo Nordisk Evaluation Deal

Vivani Medical has entered an agreement with Novo Nordisk for the evaluation of its semaglutide drug implant, NPM-139, designed for chronic weight management. The company also received ethics committee approval to begin its Phase 1 human clinical trial (SLIM-1) in Australia in August, with …

Vivani Medical says first SLIM-1 dosing expected in August 2026 after CEO presentation

Vivani Medical (VANI) announced that the first dosing of its SLIM-1 product is anticipated in August 2026. This information was disclosed during a presentation by CEO Dr. Adam Mendelsohn at the Emerging Growth Conference in New York on July 15, 2026. The details were …